PR Newswire Asia's news > Biotechnology

< Previous page

All Airlines/Aviation Auto Maritime/Shipbuilding Transportation Computer Hardware Computer Networks Computer Software Computer/Electronics Electronic Commerce Electronic Components High Tech Security Internet Technology Peripherals Semiconductors Electronics Gaming Consumer Electronics Mobile Entertainment Multimedia/Online/Internet Telecommunications Household/Consumer/Cosmetics Retail Supermarkets Toys Alternative Energies Chemical Mining/Metals Oil/Energy Environmental Products & Services Green Technology Art Cosmetics & Personal Care Entertainment Fashion Film & Motion Picture Jewelry Banking/Financial Service Insurance Workforce Management/Human Resources Education Higher Education Biotechnology Health Care/Hospital Infectious Disease Control Medical Equipment Medical/Pharmaceuticals Agriculture Machinery Paper/Forest Products/Containers Textiles Domestic policy Legal issues Sports Hotels and Resorts Leisure/Travel/Hotels Travel Restaurants Beer, Wine & Spirits Beverages Non-Alcoholic Beverages Food/Beverages Advertising Books Music Publishing/Information Service Television Trade show news Real Estate Construction/Building Furniture & Furnishings  |   Title only   |   Print

Next page >

88IV - PR Newswire Asia's news - Biotechnology 5 ScaleUp Bio Announces Fusionopolis Ventures Joining ADM as Shareholder The partnership supports ScaleUp Bio's next phase of growth as a precision fermentation CDMO in Asia. ... 2026-03-26T    Biotechnology   Chemical   Food/Beverages  XtalPi Holdings Announces Full Year 2025 Annual Results HONG KONG , March 25, 2026 /PRNewswire/ -- Financial Highlights: ... 2026-03-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics SYDNEY , March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation ... 2026-03-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals   Mining/Metals  Frost & Sullivan: Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition for Excellence in Platform-Driven Biological Innovation The company is acknowledged for its scalable technology platform, application diversity, and customer-centered commercialization driving multi-industry adoption. ... 2026-03-25T    Biotechnology   Chemical   Computer/Electronics  Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics - Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 ... 2026-03-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company BEIJING , March 25, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated ... 2026-03-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world to ... 2026-03-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture SHANGHAI , March 25, 2026 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has released its annual ... 2026-03-25T    Banking/Financial Service   Biotechnology   Computer/Electronics   Health Care/Hospital  VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial Pivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028 A 'truly transformative' regenerative medicine targeting a multi-million patient population with no existing ... 2026-03-25T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical Equipment  HanchorBio Advances Toward TWSE Innovation Board Listing to Accelerate Global Clinical Development, Platform Expansion, and International Partnering Listing milestone positions HanchorBio to strengthen institutional visibility, advance its FBDB™ platform, and expand a growing pipeline spanning oncology and broader immune-mediated diseases ... 2026-03-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals
< Previous page	Next page >